Wuxi AppTec CoWUXIF 81 Return-on-Tangible-Equity is 23.55% as of Mar. 2026, which is 13% above its 10-year median of 20.92. GuruFocus rates WUXIF with a GF Score™ of 81/100 and a GF Value™ of $14.57 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 192 Medical Diagnostics & Research companies, Wuxi AppTec Co ranks better than 78.65% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Wuxi AppTec Co's annualized net income for the quarter that ended in Mar. 2026 was $2,700 Mil. Wuxi AppTec Co's average shareholder tangible equity for the quarter that ended in Mar. 2026 was $11,463 Mil. Therefore, Wuxi AppTec Co's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 23.55%.
The historical rank and industry rank for Wuxi AppTec Co's Return-on-Tangible-Equity or its related term are showing as below:
WUXIF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 12 Med: 20.92 Max: 29.12
Current: 29.12
During the past 12 years, Wuxi AppTec Co's highest Return-on-Tangible-Equity was 29.12%. The lowest was 12.00%. And the median was 20.92%.
WUXIF's Return-on-Tangible-Equity is ranked better than 78.65% of 192
companies
in the Medical Diagnostics & Research industry
Industry Median: -0.405
vs WUXIF: 29.12
Wuxi AppTec Co (OTCPK:WUXIF) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Wuxi AppTec Co Return-on-Tangible-Equity Related Terms
Wuxi AppTec Co Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Wuxi AppTec Co's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WUXIF vs TMO, DHR, IDXX: Return-on-Tangible-Equity Comparison
For the Diagnostics & Research subindustry, Wuxi AppTec Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wuxi AppTec Co Return-on-Tangible-Equity vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Wuxi AppTec Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Wuxi AppTec Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 23.55% mean?
Wuxi AppTec Co (WUXIF) has a Return-on-Tangible-Equity of 23.55% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Wuxi AppTec Co and its competitors. This is 13% above median its historical median of 20.92. Over the past decade, Wuxi AppTec Co's Return-on-Tangible-Equity has ranged from 12.00 to 29.12. According to the industry distribution chart, Wuxi AppTec Co ranks #41 out of 192 companies in the Medical Diagnostics & Research industry, placing it in the top 21.4%.
Is Wuxi AppTec Co's Return-on-Tangible-Equity too high?
Wuxi AppTec Co's current Return-on-Tangible-Equity of 23.55% is 13% above median its 10-year median of 20.92. Over the past 10 years, this metric has ranged from a low of 12.00 to a high of 29.12. Based on the distribution chart, Wuxi AppTec Co ranks #41 out of 192 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Wuxi AppTec Co has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Wuxi AppTec Co's Return-on-Tangible-Equity compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Wuxi AppTec Co ranks #41 out of 192 companies for Return-on-Tangible-Equity. This places Wuxi AppTec Co in the top 21% of its industry — outperforming the majority of peers. Historically, Wuxi AppTec Co's own Return-on-Tangible-Equity has ranged from 12.00 to 29.12 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Diagnostics & Research company?
A good Return-on-Tangible-Equity depends on the Medical Diagnostics & Research industry context. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Wuxi AppTec Co and its competitors. Wuxi AppTec Co's current Return-on-Tangible-Equity is 23.55%, which is 13% above median its own 10-year median of 20.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wuxi AppTec Co stock overvalued right now?
Based on GuruFocus' analysis, Wuxi AppTec Co (WUXIF) is currently considered Significantly Overvalued. The stock's GF Value™ is $14.57, compared to a current price of $21.19 — trading 45.4% above its estimated fair value. The current Return-on-Tangible-Equity is 23.55%, which is 13% above median its 10-year median of 20.92. Wuxi AppTec Co's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Wuxi AppTec Co (WUXIF), the current Return-on-Tangible-Equity is 23.55% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wuxi AppTec Co (WUXIF) Overvalued in 2026?
Based on GuruFocus' analysis, Wuxi AppTec Co stock appears to be overvalued.
The current stock price of $21.19 is trading 45.4% above its estimated GF Value™ of $14.57.
GuruFocus considers Wuxi AppTec Co to be Significantly Overvalued.
Key valuation signals for WUXIF:
Return-on-Tangible-Equity: 23.55% (13% above median its 10-year median of 20.92)
GF Value™: $14.57 vs. price of $21.19 (45.4% above fair value)
No single metric tells the full story. See the WUXIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by PRC, Europe, and other regions.
81GF Score
Get the complete analysis for WUXIF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WUXIF has been successfully added to your 
